Events | Incidence rate (per 100 days) | |
---|---|---|
Anakinra 100 mg/day (194 total days) | ||
Serious events | ||
Hospitalized to rule out thrombus | 1 | 0.5 |
Non-serious events | ||
Injection site reaction | 3 | 1.5 |
Oral thrush | 1 | 0.5 |
Other | 2 | 1.0 |
Anakinra 200 mg/day (1371 total days) | ||
Serious events | ||
Pulmonary artery hypertension | 1 | 0.1 |
Pre-syncope | 1 | 0.1 |
Non-cardiac chest pain | 1 | 0.1 |
Non-serious events | ||
Upper respiratory infection | 5 | 0.4 |
Alopecia | 2 | 0.2 |
Edema | 2 | 0.2 |
Vaginal yeast infection | 1 | 0.1 |
Other | 9 | 0.7 |
Anakinra 300 mg/day (322 total days) | ||
Serious events | ||
• None | 0 | 0 |
Non-serious events | ||
• Upper respiratory infection | 2 | 0.6 |
• Vaginal yeast infection | 1 | 0.3 |
• Other | 2 | 0.6 |